CoQ10 200 mg

CoQ10 200 mg

NOW4.8 (5,374 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$21.91 $0.36 per serving

Product analysis

55 out of 100

CoQ10 200 mg may support blood-vessel function and related heart-health measures in some adults, at a reasonable serving cost. Missing preparation details make it harder to match the supplement to the forms behind those findings.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The CoQ10 form is unspecified. Its preparation quality and absorption therefore cannot be compared confidently.

Ingredient Transparency63

The CoQ10 amount is clearly stated. Its unspecified form limits comparisons with preparations used for particular benefits.

Value For Money60

The CoQ10 serving appears reasonably priced. Comparing preparations as well as amounts would help judge value more closely.

Customer Satisfaction91

Customer feedback is very positive across thousands of ratings. The broad review history describes satisfaction without establishing heart or energy benefits.

Product Focus74

The clearest connection is to blood-vessel and other heart-health measures in selected adults. Fatigue support is more limited, and calorie-burning or longer-life benefits remain uncertain.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.36
Customer rating
4.8 · 5,374 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q10 may contribute to blood-pressure, lipid and blood-vessel measures in selected adults, although studies have mixed results. The declared conventional CoQ10 amount supports the saved exposure comparison. This does not establish prevention of cardiovascular events or a benefit specific to an assumed oxidation state or delivery system.

How this product is rated for Heart Health

Ingredient fit93

The declared active ingredients are focused on the heart-related roles included here. The relevant declared amounts fully meet or nearly meet the saved exposure comparison; this does not establish an optimal regimen.
Goal fit
The declared active ingredients are focused on the heart-related roles included here.
Dose adequacy
The relevant declared amounts fully meet or nearly meet the saved exposure comparison; this does not establish an optimal regimen.

Pathways60

The strongest saved connection is to blood-vessel function. Coverage across other heart-related roles is limited.
Depth
The strongest saved connection is to blood-vessel function.
Breadth
The broader saved findings cover blood-vessel function. .

Evidence98

Coenzyme Q-10 leads the saved evidence finding. Accepted preparation matches do not remove the ingredient-specific limitations described above.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution in the saved comparison; its clinical limitations still apply.
Studied preparation
The saved finding accepts the preparations used for its included ingredients; it does not establish that every labelled preparation matches a clinical trial.

Formulation logic100

The saved checks find no missing required partner or configured conflict. The included amounts pass the minimum comparison screen.
Partner coverage
The included ingredients do not lack a required partner under the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients included in this amount screen meet its minimum comparison level; that level is not a proven effective dose.
Study evidence
Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 at 200 mg relates to mitochondrial energy production. Selected skin-aging findings came from a particular water-soluble preparation, so generic CoQ10 cannot be assumed to deliver the same wrinkle or smoothness effects, or to extend life.

How this product is rated for Longevity

Ingredient fit93

The assessed ingredients are closely focused on healthy aging, although the formula is also linked to other goals. The assessed amount reaches the saved reference level.
Goal fit
The assessed ingredients are closely focused on healthy aging, although the formula is also linked to other goals.
Dose adequacy
The assessed amount reaches the saved reference level.

Pathways40

The strongest saved connection is mitochondrial energy production, with moderate coverage. One aging-related pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.
Depth
The strongest saved connection is mitochondrial energy production, with moderate coverage.
Breadth
One aging-related pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.

Evidence30

Coenzyme Q-10 supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters. The assessed preparation is not identified as a studied preparation.
Evidence strength
Coenzyme Q-10 supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters.
Studied preparation
The assessed preparation is not identified as a studied preparation.

Formulation logic100

The assessed ingredients can work alone or have their required partner. No configured ingredient conflict was found in the supplied assessment. All assessed ingredients reach the saved minimum amount threshold.
Partner coverage
The assessed ingredients can work alone or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
All assessed ingredients reach the saved minimum amount threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 has limited support for blood-pressure, lipid and vessel-function markers in adults with abnormal blood lipids. The findings concern measured markers and do not establish cardiovascular-event prevention. Higher amounts do not establish proportionately larger benefits.

How this product is rated for Cardiovascular Support

Ingredient fit93

The declared actives are focused on the evaluated cardiovascular-related ingredients. The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.
Goal fit
The declared actives are focused on the evaluated cardiovascular-related ingredients.
Dose adequacy
The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.

Pathways60

Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect. The recorded reach is concentrated in one cardiovascular role.
Depth
Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect.
Breadth
The recorded reach is concentrated in one cardiovascular role.

Evidence88

Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations. The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.
Evidence strength
Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations.
Studied preparation
The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.

Formulation logic100

The evaluated ingredients have no missing required partner or configured conflict. All counted amounts pass the minimum comparison.
Partner coverage
No required partner is missing from the counted ingredients; this does not establish an additional combination benefit.
Conflicts
No configured conflict was identified among the evaluated ingredients.
Effective doses
All counted ingredients pass the minimum amount comparison; passing it does not prove a clinical cardiovascular benefit.
Study evidence
Inflammation
Impact
High effect
B Ingredient FitD PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 is relevant to oxidative and mitochondrial stress, with limited evidence for changes in inflammatory markers. The studied ubiquinone regimen used 300 mg daily for 12 weeks in people with coronary artery disease taking statins; some markers changed while others did not. This serving supplies 200 mg, so its amount does not establish the same regimen or routine clinical benefit.

How this product is rated for Inflammation

Ingredient fit80

CoQ10 is the main relevant ingredient. The declared amount supports the saved contribution, subject to the ingredient’s specific evidence limits.
Goal fit
CoQ10 provides the main relevant ingredient focus, with a relatively focused formula.
Dose adequacy
The 200 mg serving differs from the reviewed 300 mg daily regimen; the amount alone does not establish equivalent benefit.

Pathways46

The contribution is concentrated in oxidative and mitochondrial stress, rather than broad coverage of the assessed inflammatory routes.
Depth
CoQ10 supplies the main contribution in oxidative and mitochondrial stress.
Breadth
Only oxidative and mitochondrial stress reaches the coverage threshold; the other assessed routes add no coverage.

Evidence93

CoQ10 supplies the main evidence connection, with a reviewed ubiquinone preparation and context-limited biomarker findings.
Evidence strength
CoQ10 leads the evidence finding, based on limited biomarker results in statin-treated coronary artery disease.
Studied preparation
The supplied policy treats unspecified CoQ10 as ordinary ubiquinone, the reviewed preparation.

Formulation logic100

CoQ10 can contribute independently, with no configured ingredient conflict identified.
Partner coverage
CoQ10 can contribute without a required companion ingredient.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
CoQ10 meets the amount threshold used for inclusion; this is not a proven effective clinical dose.
Study evidence
Metabolism Support
Impact
High effect
A Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q-10 helps the cellular machinery that transfers energy, but this normal role does not establish that supplementation increases whole-body calorie expenditure. The supplied studies concern metabolic markers rather than a general increase in metabolic rate. Its known amount receives a saved contribution, without demonstrating thermogenesis or sustained weight loss.

How this product is rated for Metabolism Support

Ingredient fit93

Coenzyme Q-10 supplies the saved ingredient contribution, but its normal cellular role does not establish increased whole-body energy expenditure.
Goal fit
The counted ingredients dominate the formula, although links to other goals reduce focus.
Dose adequacy
The counted amounts reach the saved comparison range; that range is not a proven dose for increasing calorie expenditure.

Pathways54

The strongest saved functional coverage concerns mitochondrial energy and fat oxidation. That mechanism does not by itself establish greater whole-body energy expenditure.
Depth
The strongest saved contribution concerns mitochondrial energy and fat oxidation, with partial functional coverage.
Breadth
The saved findings cover mitochondrial energy and fat oxidation; other functions remain less supported.

Evidence75

Coenzyme Q-10 is the strongest saved evidence contributor. The supplied scientific context does not establish a routine increase in calorie expenditure.
Evidence strength
Coenzyme Q-10 supplies the strongest saved evidence contribution; this does not override limitations in the direct energy-expenditure findings.
Studied preparation
The counted amounts match preparations accepted in the saved comparison.

Formulation logic100

The counted ingredients can contribute independently and no configured conflict is found. Their known amounts pass the saved minimum.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The counted amounts pass the saved minimum, which does not establish a proven increase in energy expenditure.
Study evidence
Energy
Impact
Moderate effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 at 200 mg relates to cellular energy production and may offer limited fatigue support. The saved findings use an unidentified-form category, so the evidence for specific ubiquinone or ubiquinol preparations is only partly applicable.

How this product is rated for Energy

Ingredient fit93

The assessed active ingredient fits the energy goal, while also relating to other health uses. The credited ingredient reaches the full amount used in the saved assessment.
Goal fit
The assessed active ingredient fits the energy goal, while also relating to other health uses.
Dose adequacy
The credited ingredient reaches the full amount used in the saved assessment.

Pathways17

The strongest saved contribution concerns mitochondrial energy production, with partial coverage. No selected energy pathway reaches the saved threshold for substantial coverage.
Depth
The strongest saved contribution concerns mitochondrial energy production, with partial coverage.
Breadth
No selected energy pathway reaches the saved threshold for substantial coverage.

Evidence27

Coenzyme Q-10 provides the strongest saved evidence among ingredients at an assessed effective amount; the practical benefit remains dependent on context. The CoQ10 redox form is unidentified, so it is not matched to a studied preparation.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence among ingredients at an assessed effective amount; the practical benefit remains dependent on context.
Studied preparation
The CoQ10 redox form is unidentified, so it is not matched to a studied preparation.

Formulation logic100

The credited ingredients can contribute independently or have their required partners. No configured ingredient conflicts were recorded in the saved findings. All credited ingredients meet the saved minimum amount.
Partner coverage
The credited ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflicts were recorded in the saved findings.
Effective doses
All credited ingredients meet the saved minimum amount.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10
200 mg 41
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Vegetarian
Report overview
Coenzyme Q-10 · 200 mg OverallScore41
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyC Value
Each serving provides 200 mg of CoQ10, but the saved facts do not identify its form. The missing form makes a form-specific comparison of absorption and amount uncertain.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The CoQ10 form is not identified in the saved facts, limiting a form-specific absorption comparison.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify the CoQ10 form, so a form-specific absorption comparison is not possible.
Formulation & Absorption Enhancers
The saved facts do not establish a specified absorption-enhancing technology or black pepper extract.

Dose, Safety & Label Transparency60

The stated CoQ10 amount is 200 mg per serving, although the form remains unknown.
Clinical Dosage Alignment
The serving contains 200 mg of CoQ10, but the unknown form prevents a form-specific assessment.
Label Transparency & Fillers
The CoQ10 amount is clear, and the evaluation records standard fillers.

Value60

A whole-product serving costs about $0.37; the evaluation places the price in the middle of the comparison. The price covers the entire product.
Price Per Effective Serving
A whole-product serving costs about $0.37; the evaluation places the price in the middle of the comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10